REENA DOANE: Open Payments
NPI 1982638235 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 19 payments from 9 companies in 2025. Trend: 2023 $787 · 2024 $431 · 2025 $535
Food & beverage: $480Education: $55
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $123 |
| Novartis Pharmaceuticals Corporation | 3 | $89 |
| Janssen Biotech, Inc. | 4 | $87 |
| SEAGEN INC. | 1 | $55 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Procept Biorobotics Corporation | 1 | $49 |
| Olympus America Inc. | 1 | $39 |
| Telix Pharmaceuticals | 1 | $24 |
| PFIZER INC. | 1 | $14 |
Products named: PLUVICTO, ERLEADA, GEMTESA, LYNPARZA, ORGOVYX, AQUABEAM ROBOTIC SYSTEM, iTIND System, ILLUCCIX.
Industry payments across TX — which companies pay providers there.
